Hudock, Inc. Edwards Lifesciences Corp Transaction History

Hudock, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$101.96 - $128.34 $41,191 - $51,849	-404 Reduced 24.05%	1,276 $150,000
Q4 2021 Jan 19, 2022	SELL	$106.37 - $130.68 $3,829 - $4,704	-36 Reduced 2.1%	1,680 $217,000
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $65,825 - $88,030	1,144 Added 200.0%	1,716 $118,000
Q2 2019 Jul 30, 2019	BUY	$55.74 - $64.41 $668 - $772	12 Added 2.14%	572 $105,000
Q3 2018 Oct 16, 2018	SELL	$45.7 - $58.03 $639 - $812	-14 Reduced 2.44%	560 $97,000
Q2 2018 Aug 01, 2018	BUY	$42.45 - $51.3 $594 - $718	14 Added 2.5%	574 $83,000
Q2 2017 Aug 08, 2017	BUY	N/A	560	560 $66,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.